GN shorting was almost halved in December
GN has had a difficult year on the stock market, and considering the group’s high gearing ratio combined with supply problems, expensive input costs and soaring inflation affecting consumer confidence have been a toxic mix for the Danish hearing health company.
Such factors have thus far resulted GN’s share price sliding by approx. 60% over the year, a situation also compounded by short positions taken by hedge funds, among others.
Thus far in December, however, shorting of GN’s equity has waned significantly.
The short position in GN has thus fallen from 8.9% at the end of November to 4.89% on Dec. 29, according to data from the Danish Financial Supervisory Authority (Finanstilsynet).
In Thursday trading, GN’s share price is up by 2% to DKK 157.45, having thus declined by a total of 61.7% this year.
Novo Nordisk tops list over most popular shares among new investors
Related articles
GN Group CFO quits – replacement found at ALK
For subscribers
